, Table n n of Contents
Chapter 01. The Concept of Stress Adaptation
nn n n n n n n n n n n n n
Chapter 02. Mental Health/Mental Illness: Historical and Theoretical
nn nn nn nn nn nn nn
Concepts
nn
Chapter 03. Psychopharmacology n n n n
Chapter 04. Concepts of Psychobiology
nn nn nn nn nn
Chapter 05. Ethical and Legal Issues in Psychiatric/Mental Health Nursing
n n n n n n n n n n n n n n n n n n
Chapter 06. Cultural and Spiritual Concepts Relevant to Psychiatric/Mental
n n n n n n n n n n n n n n n n
Health Nursing Chapter 07. Relationship Development
n n nn nn n n n n n n
Chapter 08. Therapeutic Communication
n n n n n n
Chapter 09. The Nursing Process in Psychiatric/Mental Health Nursing
nn nn nn nn nn nn nn nn
Chapter 10. Therapeutic Groups
nn n n n n n n
Chapter 11. Intervention With Families
n n n n n n n n n n n n n n
Chapter 12. Milieu Therapy - The Therapeutic Community
nn nn nn nn nn nn nn
Chapter 13. Crisis Intervention
nn n n n n n n
Chapter 14. Assertiveness Training
nn nn nn
Chapter 15. Promoting Self-Esteem
nn nn nn nn
Chapter 16. Anger/Aggression
nn nn nn
Management Chapter 17. The nn n n n n
Suicidal Client
n n nn
Chapter 18. Behavior Therapy n n n n
Chapter 19. Cognitive
nn n n n n
Therapy
Chapter 20. Electroconvulsive
nn nn nn
Therapy Chapter 21. The
nn n n n n n n
Recovery Model Chapter 22.
nn nn n n n n
Neurocognitive Disorders nn
Chapter 23. Substance-Related and Addictive Disorders
n n n n n n n n
Chapter 24. Schizophrenia Spectrum and Other Psychotic
nn nn nn nn nn nn nn
Disorders Chapter 25. Depressive Disorders
nn nn n n n n n n
Chapter 26. Bipolar and Related Disorders
n n n n n n n n n n n n n n n n n n
Chapter 27. Anxiety, Obsessive-Compulsive, and Related Disorders
nn nn nn nn nn nn
Chapter 28: Trauma and Stressor-Related Disorders
nn n n n n n n n n n n
Chapter 29. Somatic Symptom n n and Dissociative n n n n n n
n Disorders Chapter 30. Issues Related to Human Sexuality and
n nn nn nn nn nn nn nn nn
Gender Dysphoria Chapter 31. Eating Disorders
nn nn nn n n n n n n
Chapter 32. Personality Disorders n n n n n n
Chapter 33. Children and Adolescents
nn nn nn nn nn
Chapter 34. The Aging
nn n n n n n n
Individual
n n
Chapter 35. Survivors of Abuse or n n n n n n n n n n
n Neglect Chapter 36. Community Mental
n nn nn nn nn
Health Nursing Chapter
nn nn37. The nn n n n n
n Bereaved
n Individual Chapter 38. n n nn n n
Military Families
n n n n
,Chapter n n 01. n n Psychopharmacology
Multiple Choice nn
1. The NURSE manager on the psychiatric
n n unit was explaining to n n n n n n n n n n n n n n n n
the
n new
n staff the differences between
n typical
n and atypical n n n n nn nn n n n n n n
antipsychotics.
n n The NURSE correctly states that atypical antipsychotics: n n n n n n n n nn n n nn
A. Remain n n in n n the n n system n n longer
B. Act n n more n n quickly n n to n n reduce n n delusions
C. Produce n n fewer n n n n extrapyramidal n n n n effects
D. Are n n risk n n free n n for n n neuroleptic n n n n malignant n n n n syndrome n n n n (NMS)
CORRECT qANSWER:C kj
Atypical antipsychotics produce less D2blockade;
n n thus
n n movement disorders are n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n
less
n n of a problem. No evidence suggests that the medication remains in the system
n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n
longer nor that it acts more quicklyto reduce delusions.
n n n n The atypicals are not risk
n n n n n n n n nn nn nn n n n n n n n n n n
n free nfor NMS. n n n n
KEY: Cognitive Level: Application
n n n n n n | Integrated
n n n n Processes: n n Nursing n n Process:
n Implementation
n | Client Need: n n n n nn
Physiological Integrity: Pharmacological n n n n n n and n n Parenteral n n Therapies
2.The NURSE would assess for neuroleptic
n n n n n n n n n n n n malignant n n syndrome
(NMS) if a patient on haloperidol
n n (Haldol) n n n n nn n n nn n n n ndevelops n n a:
A. 30 nn n n n n mm n n Hg n n decrease n n n n in n n n n blood n n n n pressure n n n n reading
B. Respiratory
nn n n rate n n n n of n n n n 24 n n respirations n n n n per n n minute
C. Temperature
nn n n n n reading of n n n n 104° F
D. Pulse nn n n rate n n n n of n n n n 70 n n n n beats n n n n per n n n n minute
CORRECT qANSWER:C kj
Increased temperature is the cardinal
n nsign of NMS. This
n n n n n n n n n n n n n n n n n n n n n n BP n n n n is notn n n n n n a n n
significant
n n feature of NMS. There are no significant findings n n n n n n nn n n n n nn n n n n n nto n n support n n the
options
n n related to respirations or pulse rate. n n n n n n n n n n n n
KEY: Cognitive Level: Application
n n n n n n | Integrated
n n n n Processes: n n Nursing n n Process:
Assessment | Client Need:
n n n n n n nn
Physiological Integrity: Pharmacological n n n n n n and n n Parenteral n n Therapies
3. A patient taking
n n n n n n n n fluphenazine n n n n (Prolixin) n n complains n n of n n dry n n mouth n n n n and n n blurred
vision.
n nWhat n n n n
would the NURSE n n nn n n n n assess n n n n as n n n n the n n n n likely n n n n cause n n n n of n n n n these n n n n symptoms?
A. Decreased n n dopamine n n at n n receptor n n sites
B. Blockade n n of n n histamine
C. Cholinergic n n blockade
D. Adrenergic n n blocking
CORRECT qANSWER:C kj
Fluphenazine n n administration n n produces blockade of nn nn n n cholinergic n n receptors n n giving n n rise n n to
, anticholinergic effects,
nn n n n n such n n n n as n n n n dry n n n n mouth, n n n n blurred n n n n vision, n n n n and n n n n constipation.
KEY: Cognitive
n n Level: nApplication
n n n | Integrated
n n n n Processes: n n Nursing n n Process:
Assessment | Client Need:
n n n n n n nn
Chapter 01. The Concept of Stress Adaptation
nn n n n n n n n n n n n n
Chapter 02. Mental Health/Mental Illness: Historical and Theoretical
nn nn nn nn nn nn nn
Concepts
nn
Chapter 03. Psychopharmacology n n n n
Chapter 04. Concepts of Psychobiology
nn nn nn nn nn
Chapter 05. Ethical and Legal Issues in Psychiatric/Mental Health Nursing
n n n n n n n n n n n n n n n n n n
Chapter 06. Cultural and Spiritual Concepts Relevant to Psychiatric/Mental
n n n n n n n n n n n n n n n n
Health Nursing Chapter 07. Relationship Development
n n nn nn n n n n n n
Chapter 08. Therapeutic Communication
n n n n n n
Chapter 09. The Nursing Process in Psychiatric/Mental Health Nursing
nn nn nn nn nn nn nn nn
Chapter 10. Therapeutic Groups
nn n n n n n n
Chapter 11. Intervention With Families
n n n n n n n n n n n n n n
Chapter 12. Milieu Therapy - The Therapeutic Community
nn nn nn nn nn nn nn
Chapter 13. Crisis Intervention
nn n n n n n n
Chapter 14. Assertiveness Training
nn nn nn
Chapter 15. Promoting Self-Esteem
nn nn nn nn
Chapter 16. Anger/Aggression
nn nn nn
Management Chapter 17. The nn n n n n
Suicidal Client
n n nn
Chapter 18. Behavior Therapy n n n n
Chapter 19. Cognitive
nn n n n n
Therapy
Chapter 20. Electroconvulsive
nn nn nn
Therapy Chapter 21. The
nn n n n n n n
Recovery Model Chapter 22.
nn nn n n n n
Neurocognitive Disorders nn
Chapter 23. Substance-Related and Addictive Disorders
n n n n n n n n
Chapter 24. Schizophrenia Spectrum and Other Psychotic
nn nn nn nn nn nn nn
Disorders Chapter 25. Depressive Disorders
nn nn n n n n n n
Chapter 26. Bipolar and Related Disorders
n n n n n n n n n n n n n n n n n n
Chapter 27. Anxiety, Obsessive-Compulsive, and Related Disorders
nn nn nn nn nn nn
Chapter 28: Trauma and Stressor-Related Disorders
nn n n n n n n n n n n
Chapter 29. Somatic Symptom n n and Dissociative n n n n n n
n Disorders Chapter 30. Issues Related to Human Sexuality and
n nn nn nn nn nn nn nn nn
Gender Dysphoria Chapter 31. Eating Disorders
nn nn nn n n n n n n
Chapter 32. Personality Disorders n n n n n n
Chapter 33. Children and Adolescents
nn nn nn nn nn
Chapter 34. The Aging
nn n n n n n n
Individual
n n
Chapter 35. Survivors of Abuse or n n n n n n n n n n
n Neglect Chapter 36. Community Mental
n nn nn nn nn
Health Nursing Chapter
nn nn37. The nn n n n n
n Bereaved
n Individual Chapter 38. n n nn n n
Military Families
n n n n
,Chapter n n 01. n n Psychopharmacology
Multiple Choice nn
1. The NURSE manager on the psychiatric
n n unit was explaining to n n n n n n n n n n n n n n n n
the
n new
n staff the differences between
n typical
n and atypical n n n n nn nn n n n n n n
antipsychotics.
n n The NURSE correctly states that atypical antipsychotics: n n n n n n n n nn n n nn
A. Remain n n in n n the n n system n n longer
B. Act n n more n n quickly n n to n n reduce n n delusions
C. Produce n n fewer n n n n extrapyramidal n n n n effects
D. Are n n risk n n free n n for n n neuroleptic n n n n malignant n n n n syndrome n n n n (NMS)
CORRECT qANSWER:C kj
Atypical antipsychotics produce less D2blockade;
n n thus
n n movement disorders are n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n
less
n n of a problem. No evidence suggests that the medication remains in the system
n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n
longer nor that it acts more quicklyto reduce delusions.
n n n n The atypicals are not risk
n n n n n n n n nn nn nn n n n n n n n n n n
n free nfor NMS. n n n n
KEY: Cognitive Level: Application
n n n n n n | Integrated
n n n n Processes: n n Nursing n n Process:
n Implementation
n | Client Need: n n n n nn
Physiological Integrity: Pharmacological n n n n n n and n n Parenteral n n Therapies
2.The NURSE would assess for neuroleptic
n n n n n n n n n n n n malignant n n syndrome
(NMS) if a patient on haloperidol
n n (Haldol) n n n n nn n n nn n n n ndevelops n n a:
A. 30 nn n n n n mm n n Hg n n decrease n n n n in n n n n blood n n n n pressure n n n n reading
B. Respiratory
nn n n rate n n n n of n n n n 24 n n respirations n n n n per n n minute
C. Temperature
nn n n n n reading of n n n n 104° F
D. Pulse nn n n rate n n n n of n n n n 70 n n n n beats n n n n per n n n n minute
CORRECT qANSWER:C kj
Increased temperature is the cardinal
n nsign of NMS. This
n n n n n n n n n n n n n n n n n n n n n n BP n n n n is notn n n n n n a n n
significant
n n feature of NMS. There are no significant findings n n n n n n nn n n n n nn n n n n n nto n n support n n the
options
n n related to respirations or pulse rate. n n n n n n n n n n n n
KEY: Cognitive Level: Application
n n n n n n | Integrated
n n n n Processes: n n Nursing n n Process:
Assessment | Client Need:
n n n n n n nn
Physiological Integrity: Pharmacological n n n n n n and n n Parenteral n n Therapies
3. A patient taking
n n n n n n n n fluphenazine n n n n (Prolixin) n n complains n n of n n dry n n mouth n n n n and n n blurred
vision.
n nWhat n n n n
would the NURSE n n nn n n n n assess n n n n as n n n n the n n n n likely n n n n cause n n n n of n n n n these n n n n symptoms?
A. Decreased n n dopamine n n at n n receptor n n sites
B. Blockade n n of n n histamine
C. Cholinergic n n blockade
D. Adrenergic n n blocking
CORRECT qANSWER:C kj
Fluphenazine n n administration n n produces blockade of nn nn n n cholinergic n n receptors n n giving n n rise n n to
, anticholinergic effects,
nn n n n n such n n n n as n n n n dry n n n n mouth, n n n n blurred n n n n vision, n n n n and n n n n constipation.
KEY: Cognitive
n n Level: nApplication
n n n | Integrated
n n n n Processes: n n Nursing n n Process:
Assessment | Client Need:
n n n n n n nn